Brand: LA Pharma
Stanozolol LA® 5 mg is the lower-strength tablet in the LA Pharma stanozolol range. Stanozolol was developed in 1959 and approved for human use. In tablet form, it's used to treat anemia, which is a low red blood cell count, and hereditary angioedema, a condition that causes swelling. It has also been used in breast care for women. In medicine, the tablet doses are small, which is why a 5 mg tablet is a natural fit. In strength-training literature, stanozolol is valued for strength and hard, quality muscle without any water retention. The 200-tablet bottle is simply a bulk format of the same compound.
Stanozolol LA® is stanozolol, a DHT-based steroid. A small chemical change at the 17th carbon lets it survive digestion, which is why it works as a tablet. That change also puts stress on the liver. It doesn't convert into estrogen, so it doesn't hold water. Each tablet contains 5 mg, which is half the strength of the 10 mg tablet.
It is a stanozolol tablet from LA Pharma, Thailand, with 5 mg per tablet and 200 tablets per bottle.
Only the strength per tablet. Both contain stanozolol from LA Pharma, and the 5 mg tablet is half the strength of the 10 mg tablet.
No. It doesn't convert into estrogen, which is why it's usually described as a dry compound.
It's considered moderately hard on the liver, because the oral form is 17-alpha-alkylated. Its effect on cholesterol is also well documented.
They share the same pharmacology and half-life. The differences are the strength per tablet and the pack size.
Stanozolol was approved by the FDA in the past for specific medical uses such as hereditary angioedema, but it is no longer widely marketed for human use. This specific product is not an approved medicine. In the United States, stanozolol is a Schedule III controlled substance.
No. Non-prescribed use is regulated or prohibited in most countries.
Explore trusted products, clear information and support for your fitness journey.
Subscribe Now